TCL Archive In Brief: Christopher Walsh Named Dana-Farber President; Sachs Leaves NCI; Acoustic Neuroma Conference August 16, 1991
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive CDC Contribution To National Dialogue Raises Questions About Ties With ACS. September 22, 2000